While the TAC group showed numerical trends toward greater improvements in SDAI, CDAI, and CRP, these differences did not reach statistical significance.
← all excerpts
Add-on iguratimod or tacrolimus in methotrexate in patients with rheumatoid arthritis not achieving remission with methotrexate: a retrospective propensity score-matched study.
1
—
—